Bevacizumab beats Photodynamic therapy for myopic SRN

- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -

Is Bevacizumab Better Than Photodynamic Therapy for Myopic Subretinal Neovascularization?

Posted By Dr. Ari Weitzner On September 21, 2009 @ 9:40 am In Retina | Comments Disabled

Yet another nail in the coffin for laser for macular disease. A study in AJO this month demonstrated superior results for Bevacizumab compared to photodynamic therapy (PDT) for myopic subretinal neovascularization (SRN). It would seem a few years from now, we will look at laser treatment for the macula like we look at blood-letting. Oh well- it’s great progress!

Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com

URL to article: http://eyedocnews.com/002199-bevacizumab-better-than-pdt-for-myopic-choroidal-neovascularization/

Click here to print.